Association of serum magnesium with metabolic syndrome and the role of chronic kidney disease: A population‐based cohort study with Mendelian randomization
Diabetes, Obesity and Metabolism · 2024
DOI: 10.1111/dom.15497 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Diabetes, Obesity and Metabolism, 2024. Verfasst von Nuha Shugaa Addin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany. Hauptthemen laut MEDLINE: Metabolic Syndrome, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Münchner Zentrum für Gesundheitswissenschaften, Ludwig-Maximilians-Universität München, Bundesministerium für Bildung und Forschung (BMBF), Hanns-Seidel-Stiftung.
Abstract (Originalsprache)
Objectives
To assess the association of serum magnesium with prevalent and incident metabolic syndrome (MetS) and its individual components in the general population and to examine any effect modification by chronic kidney disease (CKD) status.
Methods
We analysed longitudinal data from the population‐based KORA F4/FF4 study, including 2996 participants (387 with CKD) for cross‐sectional analysis and 1446 participants (88 with CKD) for longitudinal analysis. Associations with MetS, as well as single components of MetS, were assessed by adjusted regression models. Nonlinearity was tested by restricted cubic splines and analyses were stratified by CKD. Causality was evaluated by two‐sample Mendelian randomization (MR).
Results
Serum magnesium (1 SD) was inversely associated with prevalent MetS (odds ratio [OR] 0.90, 95% confidence interval [CI] 0.83, 0.98). The association was more pronounced in individuals with CKD (OR 0.75, 95% CI 0.59, 0.94). Among MetS components, serum magnesium was negatively associated with elevated fasting glucose (OR 0.78, 95% CI 0.71, 0.88) and, again, this association was more pronounced in individuals with CKD (OR 0.67, 95% CI 0.53, 0.84). Serum magnesium was not associated with incident MetS or its components. Restricted cubic spline analysis revealed a significant nonlinear inverse relationship of serum magnesium with MetS and elevated fasting glucose. MR analysis suggested an inverse causal effect of serum magnesium on MetS (OR 0.91, 95% CI 0.85, 0.97).
Conclusion
Serum magnesium is associated with prevalent, but not incident MetS, and this effect is stronger in individuals with CKD. MR analysis implies a potential, albeit weak, causal role of magnesium in MetS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
- Institute for Medical Information Processing, Biometry and Epidemiology (IBE), Faculty of Medicine, LMU Munich, Pettenkofer School of Public Health, Munich, Germany.
- Partner Site München-Neuherberg, German Center for Diabetes Research (DZD), München-Neuherberg, Germany.
- Chair of Epidemiology, University of Augsburg, University Hospital Augsburg, Augsburg, Germany.
- Diabetes Research Group, LMU-Klinikum; Medizinische Klinik und Poliklinik IV, München, Germany.
- German Centre for Cardiovascular Research (DZHK e.V.), Munich Heart Alliance, München, Germany.
ORCID-Profile: Susanne Rospleszcz
Förderung
- Münchner Zentrum für Gesundheitswissenschaften, Ludwig-Maximilians-Universität München
- Bundesministerium für Bildung und Forschung (BMBF)
- Hanns-Seidel-Stiftung
Zitieren
APA
Shugaa Addin, N., Niedermayer, F., Thorand, B., Linseisen, J., Seissler, J., Peters, A., & Rospleszcz, S. (2024). Association of serum magnesium with metabolic syndrome and the role of chronic kidney disease: A population‐based cohort study with Mendelian randomization. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15497
Vancouver
Shugaa Addin N, Niedermayer F, Thorand B, Linseisen J, Seissler J, Peters A, et al. Association of serum magnesium with metabolic syndrome and the role of chronic kidney disease: A population‐based cohort study with Mendelian randomization. Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15497
BibTeX
@article{ShugaaAddin2024,
author = {Shugaa Addin, Nuha and Niedermayer, Fiona and Thorand, Barbara and Linseisen, Jakob and Seissler, Jochen and Peters, Annette and Rospleszcz, Susanne},
title = {Association of serum magnesium with metabolic syndrome and the role of chronic kidney disease: A population‐based cohort study with Mendelian randomization},
journal = {Diabetes, Obesity and Metabolism},
year = {2024},
doi = {10.1111/dom.15497}
}
EUVIMED